Tony Fraij

Tony Fraij is an experienced executive in the biopharmaceutical industry, currently serving as Chief Operating Officer at KBI Biopharma since May 2023. Previously, Tony held several leadership roles including General Manager and Site Head at AGC Biologics, Vice President of Technical Operations at AveXis, and Vice President and Site Head at Novartis. With a strong background in operations, Tony has overseen significant production teams and annual operating budgets across various organizations, including Sandoz and Boehringer Ingelheim. Tony's expertise includes the leadership of production operations for liquids and solids dose manufacturing, as well as a successful audit record with regulatory authorities. Tony holds an MBA from The Ohio State University Fisher College of Business and a BS in Packaging Science from Rochester Institute of Technology.